Yelena Y. Janjigian, MD*, Marion Liu, MD - Unifying Surgical-Oncology Expertise in Resectable Gastric/GEJ Malignancies: Leveraging the Evidence on Perioperative Immunotherapy Platforms to Deliver Personalized Care
The episode discusses the integration of surgical oncology expertise in treating resectable gastric and GEJ malignancies through perioperative immunotherapy.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YYF865. CME/MOC/AAPA/IPCE credit will be available until April 5, 2027. Unifying Surgical-Oncology Expertise in Resectable Gastric/GEJ Malignancies: Leveraging the Evidence on Perioperative Immunotherapy Platforms to Deliver Personalized Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent educational grant from AstraZeneca. Disclosure information is available at the beginning of the video presentation.
Sponsors
AstraZeneca
More episodes of PeerView Gastroenterology CME/CNE/CPE Video Podcast